Spdr S&p 500 Etf shares owned by Garner Asset Management Corp
Quarter-by-quarter ownership of Spdr S&p 500 Etf (SPY) shares owned by Garner Asset Management Corp
from 13F filings
Historical chart of Garner Asset Management Corp investment in Spdr S&p 500 Etf
Tip: Access up to 7 years of quarterly data
All positions including Spdr S&p 500 Etf held by Garner Asset Management Corp consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Spdr S&p 500 Etf by Garner Asset Management Corp
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 1.8k | 666.20 |
| 2025-06-30 | $1.1M | 1.8k | 617.71 |
| 2025-03-31 | $1.0M | 1.9k | 559.27 |
| 2024-12-31 | $2.0M | 3.4k | 586.29 |
| 2024-09-30 | $1.9M | 3.3k | 573.90 |
| 2024-06-30 | $1.8M | 3.3k | 544.15 |
| 2024-03-31 | $1.7M | 3.3k | 523.05 |
| 2023-12-31 | $1.4M | 2.9k | 497.37 |
| 2023-09-30 | $1.4M | 3.3k | 427.63 |
| 2023-06-30 | $1.5M | 3.3k | 443.27 |
| 2023-03-31 | $1.4M | 3.3k | 409.38 |
| 2022-12-31 | $1.2M | 3.1k | 382.40 |
| 2022-09-30 | $1.1M | 3.1k | 357.17 |
| 2022-06-30 | $1.2M | 3.3k | 377.26 |
| 2022-03-31 | $1.4M | 3.1k | 451.68 |
| 2021-12-31 | $1.5M | 3.1k | 474.98 |
| 2021-09-30 | $1.3M | 3.1k | 429.39 |
| 2021-06-30 | $1.3M | 3.1k | 428.11 |
| 2021-03-31 | $1.2M | 3.1k | 396.22 |
| 2020-12-31 | $1.2M | 3.2k | 373.78 |
| 2020-09-30 | $1.0M | 3.1k | 334.97 |
| 2020-06-30 | $941k | 3.1k | 308.42 |
| 2020-03-31 | $733k | 2.8k | 257.65 |
| 2019-12-31 | $657k | 2.0k | 322.06 |
| 2019-09-30 | $604k | 2.0k | 296.81 |
| 2019-06-30 | $595k | 2.0k | 292.96 |
| 2019-03-31 | $573k | 2.0k | 282.54 |
| 2018-12-31 | $506k | 2.0k | 250.00 |
| 2018-09-30 | $588k | 2.0k | 290.95 |
| 2018-06-30 | $547k | 2.0k | 271.06 |
| 2018-03-31 | $530k | 2.0k | 263.03 |
| 2017-12-31 | $537k | 2.0k | 267.03 |
| 2017-09-30 | $517k | 2.1k | 251.46 |
| 2017-06-30 | $496k | 2.1k | 241.83 |
More positions owned by Garner Asset Management Corp
View all positions for Garner Asset Management Corp